Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Influence of Topical, Systemic and Combined Application of Antioxidants on the Barrier Properties of the Human Skin.

Lademann J, Vergou T, Darvin ME, Patzelt A, Meinke MC, Voit C, Papakostas D, Zastrow L, Sterry W, Doucet O.

Skin Pharmacol Physiol. 2016;29(1):41-6. doi: 10.1159/000441953. Epub 2016 Jan 23.

2.

Expression of lymphatic markers and lymphatic growth factors in psoriasis before and after anti-TNF treatment.

Moustou AE, Alexandrou P, Stratigos AJ, Giannopoulou I, Vergou T, Katsambas A, Antoniou C.

An Bras Dermatol. 2014 Nov-Dec;89(6):891-7.

3.

Comparative study of hair follicle morphology in eight mammalian species and humans.

Mangelsdorf S, Vergou T, Sterry W, Lademann J, Patzelt A.

Skin Res Technol. 2014 May;20(2):147-54. doi: 10.1111/srt.12098. Epub 2013 Jun 25.

PMID:
23800212
4.

Spectroscopic methods for the photodiagnosis of nonmelanoma skin cancer.

Drakaki E, Vergou T, Dessinioti C, Stratigos AJ, Salavastru C, Antoniou C.

J Biomed Opt. 2013 Jun;18(6):061221. doi: 10.1117/1.JBO.18.6.061221. Review.

PMID:
23748702
5.

Two cases of hepatitis B in patients with moderate to severe psoriasis with ustekinumab.

Opel D, Economidi A, Chan D, Wasfi Y, Mistry S, Vergou T, Antoniou C, Sofen H.

J Drugs Dermatol. 2012 Dec;11(12):1498-501.

PMID:
23377523
6.

Spectroscopic methods for the photodiagnosis of nonmelanoma skin cancer.

Drakaki E, Vergou T, Dessinioti C, Stratigos AJ, Salavastru C, Antoniou C.

J Biomed Opt. 2013 Jun;18(6):061221. Review.

PMID:
23264965
7.

Influence of skin aging effects on the skin surface profile and the correlated distribution of topically applied sunscreens.

Gebauer V, Weigmann HJ, Schanzer S, Meinke MC, Vergou T, Sterry W, Lademann J.

J Biophotonics. 2012 Mar;5(3):274-82. doi: 10.1002/jbio.201100104. Epub 2012 Feb 6.

PMID:
22308021
8.

Pharmacodynamics of TNF-α inhibitors in psoriasis.

Vergou T, Moustou AE, Sfikakis PP, Antoniou C, Stratigos AJ.

Expert Rev Clin Pharmacol. 2011 Jul;4(4):515-23. doi: 10.1586/ecp.11.28. Review.

PMID:
22114860
9.

Comparison between TEWL and laser scanning microscopy measurements for the in vivo characterization of the human epidermal barrier.

Vergou T, Schanzer S, Richter H, Pels R, Thiede G, Patzelt A, Meinke MC, Sterry W, Fluhr JW, Lademann J.

J Biophotonics. 2012 Feb;5(2):152-8. doi: 10.1002/jbio.201100067. Epub 2011 Nov 2.

PMID:
22045692
10.

Transfer of ultraviolet photon energy into fluorescent light in the visible path represents a new and efficient protection mechanism of sunscreens.

Vergou T, Patzelt A, Richter H, Schanzer S, Zastrow L, Golz K, Doucet O, Antoniou C, Sterry W, Lademann J.

J Biomed Opt. 2011 Oct;16(10):105001. doi: 10.1117/1.3631790.

PMID:
22029345
11.

Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.

Bamias G, Evangelou K, Vergou T, Tsimaratou K, Kaltsa G, Antoniou C, Kotsinas A, Kim S, Gorgoulis V, Stratigos AJ, Sfikakis PP.

Exp Dermatol. 2011 Sep;20(9):725-31. doi: 10.1111/j.1600-0625.2011.01304.x. Epub 2011 Jun 14.

PMID:
21672030
12.

Long-term infliximab treatment for refractory type III juvenile pityriasis rubra pilaris.

Dessinioti C, Vergou T, Moustou E, Katsambas A, Antoniou C.

Eur J Dermatol. 2011 Jul-Aug;21(4):599-600. doi: 10.1684/ejd.2011.1325. No abstract available.

PMID:
21518691
13.

Central retinal vein occlusion following infliximab treatment for plaque-type psoriasis.

Vergou T, Moustou AE, Maniateas A, Stratigos AJ, Katsambas A, Antoniou C.

Int J Dermatol. 2010 Oct;49(10):1215-7. doi: 10.1111/j.1365-4632.2010.04526.x. No abstract available.

PMID:
20883414
14.

Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib.

Vergou T, Stratigos AJ, Karapanagiotou EM, Matekovits AE, Dilana KD, Tsimboukis S, Antoniou C, Chasapi V, Syrigos KN.

J Am Acad Dermatol. 2010 Aug;63(2):e56-8. doi: 10.1016/j.jaad.2009.11.589. No abstract available.

PMID:
20633793
15.

Should we consider hypohidrotic ectodermal dysplasia as a possible risk factor for malignant melanoma?

Gregoriou S, Rigopoulos D, Vergou T, Korfitis C, Menegakis G, Kontochristopoulos G.

J Cutan Med Surg. 2007 Sep-Oct;11(5):188-90.

PMID:
17942030

Supplemental Content

Loading ...
Support Center